SonicRegen is developing a bioprinting device using high intensity focused ultrasound, which is able to penetrate deep within a medium at a concentrated focal point in 3D space. Using thermoresponsive materials and specialised ultrasound transducer control, you are able to produce cell scaffolds and tissues with complex internal geometries.
Benefits of this innovative bioprinting process include:
- Overcomes limitations of other layer by layer surface printing processes by being able to create 3D cell formations deep within a medium
- Multipurpose capability providing ability to remove 3D cell formations by methods of ablation or internal cavitation
- Can be used to research in-situ tissue engineering and in-vivo patient operations
Company Details
- Founded
- -
- Address
- -, Melbourne,vic 3000,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://sonicregen.com/
- Keywords
- Bioprinting, Biotechnology, 3D Printing, Engineering, Regenerative Medicine, Ultrasound, HIFU, Tissue Engineering, Medical Equipment.
- HQ
- Melbourne, VIC
Sonicregen Questions
Sonicregen's website is http://sonicregen.com/
Sonicregen's LinkedIn profile is https://au.linkedin.com/company/sonicregen
Sonicregen's industry is
Biotechnology Research
Sonicregen's top competitors are
Biop India,
Medprin Biotech Gmbh,
Revotek,
Greiner Bio-One Apac,
Phosprint P.c.,
Rokit Healthcare Inc,
Printivo,
3dpl Co.,
Gesim Gesellschaft Fuer Silizium-Mikrosysteme Mbh,
Cyfuse Biomedical K.k..
Sonicregen's categories are Biotechnology Research
Sonicregen's founding year is 2018
